Pharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information...

Area of Science:

• Pharmacology and Osteoarthritis Management
• Biomedical Engineering and Drug Delivery
• Health Services Research and Interprofessional Care

Background:

• Osteoarthritis (OA) causes significant pain and disability, with current treatments primarily reactive and symptom-focused.
• Irreversible cartilage loss in OA necessitates a shift towards preventive, disease-modifying strategies.
• Conventional chondroprotective agents like glucosamine and chondroitin sulfate show potential for extracellular matrix restoration and lubrication, but face delivery challenges.

Purpose of the Study:

• To review the mechanistic basis of pharmacological chondroprotection in OA.
• To introduce practical frameworks for pharmacists in selecting and administering disease-modifying osteoarthritis drugs (DMOADs).
• To propose an integrated P4-4P Chondroprotection Framework for proactive, team-based OA management.

Main Methods:

• Review of mechanistic foundations for pharmacological chondroprotection.
• Introduction of a practical
• What-How-When
• framework for community pharmacists.
• Proposal of the P4-4P Chondroprotection Framework integrating predictive profiling, pharmacokinetics, biomechanics, and self-management.

Main Results:

• Conventional agents may restore extracellular matrix, attenuate catabolic enzymes, and enhance joint lubrication.
• A framework is presented to guide pharmacists in risk screening, DMOAD selection, chronotherapy, and monitoring.
• The P4-4P framework unifies predictive, preventive, personalized, and participatory approaches for OA care.

Conclusions:

• A shift towards proactive, disease-modifying OA management is crucial for preserving cartilage and improving quality of life.
• Implementation requires DMOAD guidelines, curriculum integration, multidisciplinary pathways, and robust evidence from trials.
• Synchronized DMOAD and exercise interventions hold promise for long-term structural and functional benefits in OA.